A variety of CPT code changes take effect in 2026, and many of them will make a direct impact on interventional cardiology. Arnold Seto, MD, spoke to Cardiovascular Business about these updates for a new video interview.
A growing number of private insurers are now covering these advanced technologies. Roosha Parikh, MD, told Cardiovascular Business that the hard work of SCCT and other groups has helped make this happen.
Gregg Stone, MD, spoke to Cardiovascular Business about early data from the ATHENS-HF trial. Ten heart failure patients were treated with the adjustable device, and each implant was a success.
The U.S. Food and Drug Administration has green-lit new updates that improve microvascular flow, AI-assisted harmonic imaging and elastography, which Canon will showcase at RSNA 2025.
American Medical Association President Bruce Scott, MD, explains some of the key issues facing physicians, including burnout, growing medical staffing shortages, doctors leaving rural areas, increasing patients and declining Medicare payments.
Former American College of Cardiology president Kim Allan Williams, Sr., MD, an ACC delegate to the American Medical Association House of Delegates, discusses an AMA resolution aimed at improving public awareness of low-dose CT lung cancer exams that can screen for coronary artery calcium at the same time.
Tom Price, MD, an orthopedic surgeon and secretary of Health and Human Services (HHS) during the first Trump administration, says misinformation and growing distrust of healthcare workers and institutions is negatively impacting healthcare and more needs to be done to combat it.
As cardiac CT continues to get used more and more, GE HealthCare has launched a new scanner designed to meet the needs of both outpatient imaging centers and larger hospitals.
Dean J. Kereiakes, MD, was left paralyzed after battling severe orthopedic issues for his entire career. Back in the cath lab after a long recovery, he is now stressing the importance of workplace safety among interventional cardiologists.
From new drug therapies and imaging technologies to updated prevention strategies, nearly every aspect of cardiovascular care is starting to embrace the value of coronary inflammation evaluations. Paul Ridker, MD, MPH, discussed the trend in a new interview.